Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment in Subjects With Recurrent Atrial Fibrillation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 152 participants.
Also called NCT02475642
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 152 participants
- Sponsor
- Registry
-
NCT02475642
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Belgium
- Registry status
- Unknown status
Technical summary
Registry record NCT02475642. Randomized; no masking; primary purpose treatment. Start 2014-03 (registry gives no type); primary completion 2016-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment in Subjects With Recurrent Atrial Fibrillation
- Acronym
- POWDER-AF
- Condition
- Atrial Fibrillation
- Intervention (Other)
- PVI-ADT
- Intervention (Other)
- PVI+ADT
- Lead sponsor
- VZW Cardiovascular Research Center Aalst
- Collaborator
- AZ Sint-Jan AV
Record details
- Record id
cardio:ct-nct02475642- Content hash
b353e0130e8926eb059f03a116e6c8b7f4cd4348a8d00b210a1c716197c3a511